Aninda Katragadda

Chief Financial Officer | Boston, Massachusetts, United States

Professional Overview

Aninda Katragadda is an accomplished Chief Financial Officer with extensive experience in the biotechnology and pharmaceutical industries. She is recognized for her strategic financial leadership, driving operational excellence, and enabling the growth and success of innovative life sciences organizations.

Current Role

As the Chief Financial Officer at Atavistik Bio, Aninda is responsible for overseeing all financial operations, including financial planning and analysis, accounting, treasury, and risk management. She plays a pivotal role in shaping the company's financial strategy, optimizing resource allocation, and ensuring financial integrity to support Atavistik Bio's mission of developing transformative therapies.

Career Progression

Aninda's impressive career trajectory includes senior finance roles at leading biotechnology companies. Prior to her current position, she served as the SVP of Finance at Akouos, where she played a crucial part in the company's financial strategy and operations. Aninda has also held consulting roles at Surface Oncology Inc. and leadership positions as the Head of Finance at Foghorn Therapeutics, Inc. and Voyager Therapeutics, Inc.

Academic Background

Aninda holds a Master's degree in Business Administration from a prestigious university, where she specialized in Finance. Her strong academic foundation, coupled with her extensive industry experience, enables her to bring a unique blend of strategic and technical expertise to her work.

Areas of Expertise

Aninda's core areas of expertise include financial planning and analysis, capital raising, financial reporting, treasury management, and regulatory compliance. She is adept at navigating complex financial landscapes, driving operational efficiencies, and aligning financial strategies with overall business objectives. Aninda's leadership skills and collaborative approach have been instrumental in fostering cross-functional partnerships and supporting the growth of the organizations she has served.

Professional Impact

Throughout her career, Aninda has made significant contributions to the biotechnology and pharmaceutical industries. She has played a pivotal role in securing funding, optimizing financial processes, and ensuring the financial stability and growth of the companies she has worked with. Aninda's innovative thinking and strategic vision have been instrumental in enabling her clients to achieve their long-term goals and drive positive patient outcomes.

Conclusion

With her exceptional financial acumen, industry expertise, and proven track record of success, Aninda Katragadda is poised to continue making a lasting impact as a Chief Financial Officer in the dynamic and ever-evolving biotechnology and pharmaceutical sectors.